Funder
Higher Education Commission, Pakistan
Ministry of Science and Technology of the People's Republic of China
Publisher
Springer Science and Business Media LLC
Reference86 articles.
1. WHO, 2018. WHO|Global tuberculosis report 2018. WHO Available at,
http://www.who.int/tb/publications/global_report/en/
. (Accessed: 5th October 2018).
2. Mitchison, D. A. The action of antituberculosis drugs in short-course chemotherapy. Tubercle 66, 219–225 (1985).
3. Yang, J. et al. Structural basis for targeting the ribosomal protein S1 of Mycobacterium tuberculosis by pyrazinamide. Mol. Microbiol. 95, 791–803 (2015).
4. Yadon, A. N. et al. A comprehensive characterization of PncA polymorphisms that confer resistance to pyrazinamide. Nat. Commun. 8 (2017).
5. Lu, P. et al. Pyrazinoic Acid Decreases the Proton Motive Force, Respiratory ATP Synthesis Activity, and Cellular ATP Levels. Antimicrob. Agents Chemother. 55, 5354–5357 (2011).
Cited by
61 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献